Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| RXRX | 8-K | mixed | 6/10 | Recursion Pharmaceuticals filed an 8-K announcing a $200M oversubscribed follow-on offering of 61.54M shares at $3.25/sh | Oct 15, 2026 |
| VVOS | 8-K | mixed | 6/10 | Vivos Therapeutics entered into a definitive agreement to acquire an 11% fully diluted equity stake in SOD Sciences and | Oct 15, 2026 |
| ATCH | 8-K | bullish | 7/10 | AtlasClear Holdings signed a definitive business combination agreement to acquire Ark Financial Services (parent of Daws | Oct 15, 2026 |
| DFDV | 8-K | neutral | 3/10 | DeFi Development Corp. increased the dividend rate on its Variable Rate Series C Perpetual Preferred Stock (CHAD) from 1 | Oct 15, 2026 |
| VRRM | 8-K | neutral | 4/10 | CFO Craig Conti is resigning effective November 4, 2026, to pursue an opportunity outside the industry. The company reaf | Oct 15, 2026 |
| CNDT | 8-K | neutral | 4/10 | Conduent entered into Amendment No. 4 to its credit agreement, extending the maturity date of its revolving credit commi | Oct 15, 2026 |
| RLBY | 8-K | bearish | 6/10 | Reliability Inc. dismissed its auditor Ramirez Jimenez International CPAs (RJI) and engaged Weinberg & Company, P.A. as | Oct 15, 2026 |
| OBAI | 8-K | neutral | 2/10 | Our Bond, Inc. filed an 8-K confirming a 1-for-20 reverse stock split, effective October 19, 2026. The split will reduce | Oct 15, 2026 |
| PAII | 8-K | neutral | 5/10 | Pyrophyte Acquisition Corp. II (PAII) entered into a definitive Business Combination Agreement to acquire Sakuu Corporat | Oct 15, 2026 |
| OPNW | 8-K | neutral | 4/10 | OpenWorld announced a non-binding term sheet with Meridian to establish a tokenized financing program of up to $1 billio | Oct 15, 2026 |
| REAL | 8-K | bullish | 6/10 | The RealReal entered into a new $150M senior secured term loan and $25M revolving credit facility with Fortress Credit C | Oct 15, 2026 |
| ASPI | 8-K | bullish | 6/10 | ASP Isotopes Inc. announced that its subsidiary, Quantum Leap Energy LLC (QLE), signed a binding Heads of Agreement with | Oct 15, 2026 |
| CCC | 8-K | bullish | 7/10 | CCC Intelligent Solutions Holdings Inc. has entered into a definitive agreement to be acquired by a consortium led by GT | Oct 15, 2026 |
| MRSH | 8-K | neutral | 5/10 | Marsh reported Q3 2026 GAAP EPS of $1.69 and adjusted EPS of $2.03, with revenue of $6.9B (+8% GAAP, +5% underlying). Th | Oct 15, 2026 |
| FMC | 8-K | bearish | 8/10 | FMC issued a preliminary Q3 2026 pre-announcement slashing revenue guidance to $65M-$125M (from prior $850M-$900M) and A | Oct 15, 2026 |
| CMC | 8-K | bullish | 6/10 | CMC reported a strong Q4 fiscal 2026 beat, with adjusted EPS of $2.09 (+21.9% vs consensus $1.71) and revenue of $2.66B | Oct 15, 2026 |
| OCGN | 8-K | neutral | 5/10 | Ocugen posted an October 2026 corporate presentation on its website, providing a pipeline update across three gene thera | Oct 15, 2026 |
| SURG | 8-K | neutral | 2/10 | SurgePays filed an 8-K to announce the posting of an updated October 2026 investor presentation on its website. The fili | Oct 15, 2026 |
| BSVN | 8-K | bearish | 6/10 | Bank7 Corp. reported Q3 2026 GAAP diluted EPS of $1.06 on net income of $10.20M, missing the $1.16 consensus estimate by | Oct 15, 2026 |
| JSPR | 8-K | neutral | 3/10 | Jasper Therapeutics completed enrollment of the IgA nephropathy (IgAN) cohort in its Phase 2 basket study of vensobafusp | Oct 15, 2026 |
| VBIO | 8-K | neutral | 3/10 | Valion Bio announced that its wholly owned CDMO subsidiary, Velocity Bioworks, completed an initial feasibility evaluati | Oct 15, 2026 |
| MAN | 8-K | bearish | 6/10 | ManpowerGroup reported Q3 2026 GAAP EPS of $0.71, well below the adjusted $1.01 consensus, and revenue of $4.84B missed | Oct 15, 2026 |
| ALL | 8-K | neutral | 3/10 | Allstate disclosed estimated catastrophe losses of $220 million ($173 million after-tax) for September 2026, bringing Q3 | Oct 15, 2026 |
| MAN | 8-K | neutral | 3/10 | ManpowerGroup announced a planned CEO succession: President and Chief Strategy Officer Becky Frankiewicz will become CEO | Oct 15, 2026 |
| FHN | 8-K | mixed | 6/10 | First Horizon reported a GAAP net loss of $0.20 per share for Q3 2026, driven by a $473M pre-tax loss on the pending sal | Oct 15, 2026 |
| ROCK | 8-K | bullish | 6/10 | Gibraltar Industries (ROCK) has agreed to sell its D.S. Brown infrastructure business to Saint-Gobain for $208 million i | Oct 15, 2026 |
| PLUG | 8-K | neutral | 4/10 | Plug Power issued a preliminary Q3 2026 business update, reporting expected revenue growth >10% YoY, continued gross mar | Oct 15, 2026 |
| AQST | 8-K | bullish | 7/10 | Aquestive Therapeutics announced that the FDA has accepted its resubmission of the New Drug Application (NDA) for Anaphy | Oct 15, 2026 |
| OACC | 8-K | bearish | 6/10 | Oaktree Acquisition Corp. III Life Sciences disclosed that 13,326,977 Class A ordinary shares were tendered for redempti | Oct 15, 2026 |
| KMB | 8-K | neutral | 4/10 | Kimberly-Clark released preliminary Q3 2026 results showing a 0.4% net sales decline and a 1.3% organic sales decline, w | Oct 15, 2026 |